Roots of epilepsy may lie in oft-ignored brain cellsAugust 15, 2005Star-shaped brain cells that are often overlooked by doctors and scientists as mere support cells appear to play a key role in the development of epilepsy, researchers say in a study published on-line August 14 in Nature Medicine. It's one of the first times scientists have produced firm evidence implicating the cells, known as astrocytes, in a common human disease. Scientists found that astrocytes can serve as ground zero in the brain, setting off a harmful cascade of electrical activity in the brain by sending out a brain chemical that triggers other brain cells to fire out of control. While it's impossible to tell at this early stage what effect the finding will have on treatment, the investigators at the University of Rochester Medical Center are hopeful the results will give doctors and pharmaceutical firms a new target in efforts to treat and prevent the disease. "This opens up a new vista in efforts to treat epilepsy. It might be possible to treat epilepsy not by depressing or slowing brain function, as many of the current medications do, but by targeting brain cells that have been completely overlooked," says Maiken Nedergaard, M.D., Ph.D., professor in the Department of Neurosurgery and a researcher in the Center for Aging and Developmental Biology, who led the research. "We are hopeful that someday, this will be very beneficial to patients," When most people and many scientists think of brain cells, they think of neurons, the nerve cells that send electrical signals and are at the heart of what is considered to be brain activity. In diseases like Alzheimer's, Parkinson's and Huntington's diseases, it's the neurons that become sick and die, and so they are the focus of intense study. But neurons represent just a small proportion of brain cells. Astrocytes are present in vastly greater numbers - there are approximately 10 times as many astrocytes as neurons in the human brain. Nedergaard is part of a growing group of scientists who are focusing on the pivotal role that astrocytes may play in several human diseases. "The main function of astrocytes is to maintain a healthy environment for neurons," says Nedergaard, whose study was funded by the National Institute of Neurological Disorders and Stroke. "The electrical signaling in the brain is so sophisticated that it's crucial that the environment be optimal. There's not much room for error. When the astrocytes start acting abnormally, it's easy to see how serious disease might result." Last year she showed that astrocytes magnify the damage to neurons after spinal cord injury. And currently she's looking at their role in Alzheimer's disease. Nedergaard notes that in epilepsy, scientists have long known that an early sign of the disease in the brain are abnormal cells called reactive astrocytes - over-sized, bloated, star-shaped cells that no longer function properly. "People have thought that reactive astrocytes were caused by epilepsy, not that they could be the cause." In the study, Nedergaard and colleagues showed that astrocytes actually generate seizure activity, and the team linked astrocytes to a brain chemical long known to be a key player in the development of epilepsy. They showed that glutamate, which hypes up neurons and can make them fire uncontrollably, is released by astrocytes and can trigger seizure-like activity in the brain. Then the team tested medications currently used to treat the disease. Epilepsy describes a condition in the brain where neurons start firing wildly and uncontrollably, sometimes resulting in seizures, and most medications aim to reduce such firing. The team showed that agents like gabapentin and valproate reduced the type of chemical signaling that causes astrocytes to release glutamate. According to Nedergaard, many scientists have thought that epilepsy occurs when neurons that normally inhibit or slow down other neurons lose their power, as if the brakes on a speeding car were faulty. Current medications are aimed at making those molecular "brakes" more powerful and reining signals back in. But such drugs have side effects like drowsiness. Her work opens up a new avenue to understand the disease. "The potential role of astrocytes in the generation of epilepsy has been largely ignored," says Michel Berg, M.D., medical director of the Strong Epilepsy Center. "Epilepsy involves a re-organization of the brain's pathways, in a way that is not completely understood, that results in recurrent seizures. Currently we have drugs to treat seizures, but not to prevent the whole process. Perhaps someday there will be ways to intervene before the circuitry is re-written, to prevent epilepsy completely." More than 2 million Americans have epilepsy. Current medications stop seizures in about two-thirds of patients, but others often struggle for years or even a lifetime to cope with symptoms including seizures. Surgery to remove a small amount of troublesome brain tissue is often successful in such cases. The disease can come about as a result of a brain injury or because of genetic abnormalities in the way the brain develops. In addition to Nedergaard, the team from the University's Department of Neurosurgery included Guo-Feng Tian and Weiguo Peng, research assistant professors; post-doctoral associates Takahiro Takano and Nanhong Lou; technical associate Qiwu Xu; and graduate student Nancy Ann Oberheim. Other authors include neurosurgeon Hooman Azmi from the New Jersey Medical School; Jane Lin and Jian Kang of New York Medical College in Valhalla; and Ron Zielke of the University of Maryland. University of Rochester Medical Center |
|||||||||||||||||||||
| Related Epilepsy Current Events and Epilepsy News Articles Greater certainty in monitoring 3 therapeutic medications is facilitated by new CRMs To help bring greater certainty to the measurement of medication levels in a patient's bloodstream for three drugs with narrow therapeutic ranges, the U.S. Pharmacopeial Convention (USP) is releasing new certified reference materials (CRMs). Theory about long and short-term memory questioned by UCL scientists The long-held theory that our brains use different mechanisms for forming long-term and short-term memories has been challenged by new research from UCL, published today in PNAS. Developmental delay could stem from nicotinic receptor deletion The loss of a gene through deletion of genetic material on chromosome 15 is associated with significant abnormalities in learning and behavior, said a consortium of researchers led by Baylor College of Medicine (www.bcm.edu) in a report that appears online today in the journal Nature Genetics. Protein critical for insulin secretion may be contributor to diabetes A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes. Packages of care for epilepsy in low- and middle-income countries In the second in a six part series on treating mental health problems in resource-poor settings, Caroline Mbuba and Charles Newton (Centre for Geographic Medicine Research, Kenya Medical Research Institute, Kilifi, Kenya) discuss "packages of care" for treating epilepsy. Study pinpoints key mechanism in brain development, raising question about use of antiseizure drug Researchers at the Stanford University School of Medicine have identified a key molecular player in guiding the formation of synapses - the all-important connections between nerve cells - in the brain. tudy: The new buzz on detecting tinnitus It's a ringing, a buzzing, a hissing or a clicking - and the patient is the only one who can hear it. Complicating matters, physicians can rarely pinpoint the source of tinnitus, a chronic ringing of the head or ears that can be as quiet as a whisper or as loud as a jackhammer. Researchers find a key mechanism in the development of nerve cells Chaos brews in the brains of newborns: the nerve cells are still bound only loosely to each other. How mitochondrial gene defects impair respiration, other major life functions Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals. Pancreatic fat levels may help predict diabetes, UT Southwestern researchers say Researchers have long suspected that overweight people tend to have large fat deposits in their pancreases, but they've been unable to confirm or calculate how much fat resides there because of the organ's location. Until now. More Epilepsy Current Events and Epilepsy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||